K. Osmundsen

Safety and Efficacy of Omacor in Severe Hypertriglyceridemia

H. Ginsberg, N. Shachter, S. Windsor, 1997, Journal of cardiovascular risk.

Dyslipidemia, Diabetes, and Cell Adhesion Molecules

C. Smith, C. Ballantyne, Y. Abe, 1998 .

Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins.

C. Ballantyne, A. Gotto, H. Pownall, 1999, Atherosclerosis.

A Metabolic Model for the Hypolipidemic and Antiatherogenic Effects of N-3 Fatty Acids: Effect of Omacor on Plasma Lipids

C. Ballantyne, A. Gotto, H. Pownall, 1996 .

Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n-3 fatty acids.

C. Luley, S. Westphal, M. Orth, 2000, The American journal of clinical nutrition.

Alterations in serum phosphatidylcholine fatty acyl species by eicosapentaenoic and docosahexaenoic ethyl esters in patients with severe hypertriglyceridemia.

H. Pownall, B. J. McKeone, F. Kummerow, 1997, Journal of lipid research.

Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion.

C. Smith, C. Ballantyne, Y. Abe, 1998, Arteriosclerosis, thrombosis, and vascular biology.

Double‐Blind Comparative Trial of Nuelin Depot and TheoDur with Adjusted Dosage in Asthmatic Adults

P. K. Lunde, K. Osmundsen, K. ‐. Langaker, 1981, Allergy.

[Effect of orphenadrine/paracetamol combination tablets (Norgesic) on myalgia. A double-blind comparative study using a placebo in general practice].

H. O. Høivik, N. Moe, K. Osmundsen, 1983, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

Current Distribution at the Electrodes in Zinc Electrowinning Cells

K. Bouzek, Jomar Thonstad, K. Bouzek, 1995 .